286 related articles for article (PubMed ID: 23809515)
1. Multiple distant muscular metastases from non-small cell lung carcinoma evidenced by 18F-FDG PET/CT.
Caobelli F; Pizzocaro C; Guerra UP
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):338-9. PubMed ID: 23809515
[No Abstract] [Full Text] [Related]
2. Intramedullary metastasis detected with 18F FDG-PET/CT.
Sari O; Kaya B; Kara Gedik G; Ozcan Kara P; Varoglu E
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):299-300. PubMed ID: 23067538
[No Abstract] [Full Text] [Related]
3. Intramuscular metastases on FDG PET-CT: a review of the literature.
Emmering J; Vogel WV; Stokkel MP
Nucl Med Commun; 2012 Feb; 33(2):117-20. PubMed ID: 22124361
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
5. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
[TBL] [Abstract][Full Text] [Related]
6. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
Li X; Zhang H; Xing L; Ma H; Xie P; Zhang L; Xu X; Yue J; Sun X; Hu X; Chen M; Xu W; Chen L; Yu J
Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
[TBL] [Abstract][Full Text] [Related]
7. Isolated asymptomatic skeletal muscle metastasis in a potentially resectable non-small cell lung cancer: detection with FDG PET-CT scanning.
Purandare NC; Rangarajan V; Pramesh CS; Rajnish A; Shah S; Dua SG
Cancer Imaging; 2008 Dec; 8(1):216-9. PubMed ID: 19042177
[TBL] [Abstract][Full Text] [Related]
8. Is a selective brain (18)F-FDG PET/CT study profitable in patients with small cell lung cancer?
Palomar Muñoz A; García Vicente AM; Bellón Guardia ME; González García B; Talavera Rubio MP; Pilkington Woll JP; Núñez García A; Poblete García VM; Cordero García JM; Soriano Castrejón A
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):124-9. PubMed ID: 21722995
[TBL] [Abstract][Full Text] [Related]
9. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
[TBL] [Abstract][Full Text] [Related]
10. Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
Scott WJ; Gobar LS; Hauser LG; Sunderland JJ; Dewan NA; Sugimoto JT
Chest; 1995 Apr; 107(4):1174-6. PubMed ID: 7705136
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
[TBL] [Abstract][Full Text] [Related]
12. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M
Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
[TBL] [Abstract][Full Text] [Related]
13. Multiple and solitary skeletal muscle metastases on 18F-FDG PET/CT imaging.
Nocuń A; Chrapko B
Nucl Med Commun; 2015 Nov; 36(11):1091-9. PubMed ID: 26275016
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
[TBL] [Abstract][Full Text] [Related]
15. [Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
Liu SW; Yu JM; Xing LG
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):626-9. PubMed ID: 15634527
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
Zhang H; Wroblewski K; Pu Y
Acta Radiol; 2012 Jun; 53(5):561-8. PubMed ID: 22661603
[TBL] [Abstract][Full Text] [Related]
17. Metabolic-morphologic discordant solitary skeletal muscle metastasis on [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography scan in synchronous lung and esophageal cancer: a lesson.
Lu SJ; Rodriguez-Justo M; Read S; Bomanji JB
J Clin Oncol; 2012 Mar; 30(8):e97-e101. PubMed ID: 22253463
[No Abstract] [Full Text] [Related]
18. Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
Miele E; Spinelli GP; Tomao F; Zullo A; De Marinis F; Pasciuti G; Rossi L; Zoratto F; Tomao S
J Exp Clin Cancer Res; 2008 Oct; 27(1):52. PubMed ID: 18928537
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
Vansteenkiste JF
Lung Cancer; 2005 Feb; 47(2):151-3. PubMed ID: 15639713
[No Abstract] [Full Text] [Related]
20. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]